Emre N. Ilter Emre N. Ilter

Subscribe to Emre N. Ilter's Posts
Emre N. Ilter focuses his practice on complex commercial and antitrust litigation. Emre frequently represents clients involved in antitrust price fixing and conspiracy class action litigation. He also has experience representing clients in domestic and international arbitration disputes, qui tam actions, congressional and grand jury inquiries, and mass tort litigation. In addition, Emre regularly represents clients in responding to investigative and third-party subpoenas. Read Emre N. Ilter's full bio.

Issues of Fact Must Really Be Genuine: Another District Court Ends a Relator’s FCA Suit on Scienter Grounds

By and on Sep 22, 2015
Posted In Knowledge/Scienter

On the heels of the recent Omnicare summary judgment ruling (covered in this blog) comes another scienter-based summary judgment victory for a False Claims Act (FCA) defendant in United States ex rel. Kirk v. Schindler Elevator Corp. On September 10, 2015, the U.S. District Court for the Southern District of New York granted summary judgment in...

Continue Reading

Another Reminder to Approach Dissemination of Internal Investigation Materials with Caution

By on Jul 10, 2015
Posted In Uncategorized

Companies internally investigating potential false claims issues recently received another reminder of the care that must be taken to maintain attorney-client privilege over internal investigation files and reports. In particular, companies must be very cautious with internal dissemination of any internal investigation files and reports. On June 25, in the midst of trial, a federal...

Continue Reading

New Medicare Bill Sails Through the House – Major Changes Looming If Senate Approves

By on Apr 1, 2015
Posted In Uncategorized

On March 26, 2015, the House passed the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) by an overwhelming vote of 392-37.  This is a critical bill for health care providers and attorneys to monitor as it includes many major changes, most notably the modification of the sustainable growth rate (SGR) for physician payments. ...

Continue Reading

FCA Defendant Secures Post-Trial Directed Verdict in Implied False Certification Case

By on Feb 17, 2015
Posted In Uncategorized

In United States of America ex rel. Ortolano v. Amin Radiology, a Florida federal court recently vacated a jury’s verdict for a Relator, providing another example of the critical importance of the distinction between a “condition of participation” and a “condition of payment” when assessing a False Claims Act (FCA) suit involving an implied false...

Continue Reading